July 13, 2026
Image source: AI-generated with OpenAI
US stocks beyond the technology giants are poised to report strong earnings this season, broadening the equity rally, according to Morgan Stanley strategists.
The team led by Michael Wilson said the median S&P 1500 Composite Index constituent is generating earnings-per-share growth of more than 10%, the strongest performance since the post-COVID recovery.
Moreover, analysts continue to upgrade profit estimates for the consumer discretionary and transportation sectors, both of which are closely tied to economic growth.
"We expect the broadening to continue, driven by earnings resiliency from the median stock," Wilson wrote in a note.
The second-quarter earnings season kicks off on Tuesday with reports from the major banks.
Analysts expect S&P 500 companies to post a 23% jump in profits, according to Bloomberg Intelligence data, which would rank among the strongest readings outside of recoveries from major recessions.
That sets a high bar for equity benchmarks trading near all-time highs. Investors will again focus on technology companies for clues about AI demand and whether the outlook remains strong enough to support elevated semiconductor valuations. Yahoo Finance reports.
🔊 SoundHound AI Stock’s $1.08 Billion Short Bet Just Grew — and CPI Week Is Next
SoundHound AI, Inc. enters the new week with 162.9 million shares sold short as of June 30, representing 41.3% of its public float.
Short interest—shares sold by investors betting on a decline and not yet repurchased—rose 1.2% from the prior reporting period, according to MarketBeat data published Friday.
The stock's 6.5 days-to-cover ratio means it would take an estimated 6.5 average-volume trading sessions for short sellers to close their positions.
The stock did not reflect that bearish positioning. SoundHound closed Friday at $6.64, down 0.6% on the day but up 1.4% from its July 2 close.
A total of 144.1 million shares traded between July 6 and July 10, meaning the June 30 short position equaled about 1.13 times the entire week's trading volume.
At Friday's closing price, the short position was worth approximately $1.08 billion, nearly 38% of the company's market value implied by the reported share count. TechStock² reports.
🧬 Why Q32 Bio Shares Are Trading Higher By Around 30%
Shares of Q32 Bio Inc. rose sharply in pre-market trading after the company announced it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday.
Q32 Bio shares jumped 29.6% to $14.53 in pre-market trading. Benzinga reports.
📅 Earnings season kicks off and a wave of inflation data: What to watch this week
After a relatively quiet week on Wall Street, investors are heading into a busy stretch as second-quarter earnings season begins in earnest alongside a slate of key inflation and economic data releases.
The S&P 500 closed Friday up 0.4%, finishing the week with a 1.2% gain.
The Dow Jones Industrial Average rose 0.3% on Friday but ended the week down 0.5%.
The Nasdaq gained 0.3% on Friday, closing the week up 1.7%. Yahoo Finance reports.
💊 Pfizer scores FDA approval but Wall Street reaction muted
U.S. markets are closed for the weekend, leaving investors waiting to see whether Friday's FDA approval of Padcev with Keytruda will have a meaningful impact on Pfizer's earnings.
So far, the market reaction has been muted. Pfizer slipped 0.33% to $24.17 on Friday and is down 0.62% since its July 2 close before the Independence Day holiday.
The S&P 500 gained 1.2% last week.
The FDA approved the treatment based on data showing a 47% lower risk of recurrence, disease progression, or death, a strong clinical outcome.
However, investors are looking for evidence that bladder cancer drug sales can help offset Pfizer's upcoming patent expirations. TechStock² reports.
💾 Taiwan Semiconductor’s AI Boom Rolls On: June Revenue Jumps 68%
Taiwan Semiconductor Manufacturing Co. reported a sharp increase in June revenue on Monday, reflecting continued demand for advanced chips used in artificial intelligence applications. Benzinga reports.
(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.
1) QTTB: Q32 Bio Inc.
Total gain: +83.50%
2) AGEN: Agenus Inc.
Total gain: +41.79%
3) MIMI: Mint Incorporation Limited
Total gain: +38.61%
4) TDIC: Dreamland Limited
Total gain: +16.30%
5) SKYQ: Sky Quarry Inc.
Total gain: +13.21%
The closing price of the top three market percent gainers trading near or above $3 on July 10.
(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET) Stock Analysis reports.
1) GMM: Global Mofy AI Limited
Total gain: +147.03%
The stock appeared to be moving on no notable news.
2) NVVE: Nuvve Holding Corp.
Total gain: +55.69%
The stock appeared to be moving on no notable news.
3) AARD: Aardvark Therapeutics, Inc.
Total gain: +52.00%
The stock appeared to be moving on no notable news.
(Estimate and Actual numbers represent Earnings Per Share in US Dollars)
LGPS: LogProstyle
FY 2026
Before Market Open
Estimate: N/A
Actual: N/A
FBK: FB Financial
Q2 2026
After Market Close
Estimate: 1.150
Actual: N/A
Time (ET) / Report / Period
5:25 AM - Federal Reserve Vice Chair Michelle Bowman speaks at Bank Policy Institute (BPI) roundtable - N/A
12:30 PM - Federal Reserve Governor Christopher Waller speaks at New York Association for Business Economics event - N/A
2:00 PM - Monthly Treasury Balance - June
“There is no such thing as a good or bad stock. There are only cheap stocks and expensive stocks.”
– Howard Schilit
Sourced in: Financial Shenanigans.
TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).
TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.
The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.
Investing involves risk, including the possible loss of principal.
There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.
Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.
Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.
Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.
Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.
If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.
Copyright © TradeZero 2026. All rights reserved.